The results showed elevated protein (Fig. 3E, F) and mRNA (Fig. 3G) levels of PPARγ and its downstream targets (FASN, PLIN4, FABP4) in the luminal BC cell lines RT112 and RT4. The gene discussed is FABP4; the disease is breast cancer.